SkinnyRx

• Provider Profile Name: SkinnyRx (operated by Lean Rx, Inc.)
• Website: skinnyrx.com
• Address: Sacramento, CA
• Provider Type: Direct-to-consumer telehealth platform; not itself a compounding pharmacy
• GLP-1 Products: Compounded semaglutide (injectable, sublingual drops, tablets); compounded tirzepatide (injectable and tablets)
• Pricing: Semaglutide from $199/month; tirzepatide from $299/month; free overnight shipping
• Available: Most U.S. states; no insurance accepted; FSA/HSA accepted
• FDA Warning Letter: February 20, 2026

About the Provider

SkinnyRx is operated by Lean Rx, Inc., based in Sacramento, California. According to the company’s terms of service, Lean Rx, Inc. is not a healthcare provider; medical decisions are made by independent licensed clinicians. SkinnyRx works with state-licensed 503A compounding pharmacies that operate under FDA regulation and state board of pharmacy oversight.

The platform follows a three-entity model common across consumer telehealth GLP-1 providers: Lean Rx, Inc. provides the technology infrastructure and customer support; independent licensed physicians review medical history and determine whether to prescribe; and unnamed partner compounding pharmacies prepare and ship the medication. SkinnyRx itself does not compound or dispense medication.

Note: SkinnyRx appears in the weightlossinjections.com pharmacy directory as a point of access for compounded GLP-1 medications. It is reviewed here in that context, though it functions as a telehealth platform rather than a pharmacy.

GLP-1 Compounding

SkinnyRx provides access to compounded GLP-1 medications for weight loss, including injectable semaglutide administered once weekly subcutaneously, sublingual semaglutide dissolved under the tongue, oral semaglutide tablets, and tirzepatide tablets, a dual-action GLP-1/GIP compound.

The service operates nationwide through telehealth consultations, connecting patients with licensed, board-certified physicians who evaluate medical history, determine eligibility, and create personalized dosing schedules. Prescriptions are filled through partner 503A compounding pharmacies and shipped directly to patients.

The range of formulations — injectable, sublingual, and oral tablet, across both semaglutide and tirzepatide, is broader than most comparable platforms, which typically offer injectable only.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

States Licensed In / Availability

SkinnyRx operates online and is available in most of the U.S. Eligibility depends on provider availability and state regulations. Specific states where service is unavailable are not published on the platform’s public website. No insurance is accepted; payment is by credit card, FSA, or HSA.

Telehealth Providers They Work With

SkinnyRx is itself the telehealth-affiliated pharmacy in this context. Its partner compounding pharmacies are not publicly named.

Pricing from Reviews

SkinnyRx offers compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month, with free overnight shipping included and no membership fees. Buy Now, Pay Later options are available. FSA and HSA cards are accepted.

The cheapest available price is $199/month on a 12-month plan commitment for semaglutide. Pricing across bundle plans has been a recurring source of consumer complaints.

Overall Reviews

SkinnyRx holds a 4.8-star Trustpilot rating across over 4,000 reviews, the strongest in its competitive tier by a comfortable margin. The company replies to 98% of negative reviews, typically within a week.

However, the picture is more complicated when BBB data is included. The BBB profile tells a different story from Trustpilot, with 86 complaints, a B rating, and not accredited. Recurring themes include bundle pricing confusion with patients charged $3,000+ thinking they were signing up monthly, a no-refund-once-shipped policy, and a cancellation process that requires a phone call with retention pressure.

U.S. News characterized SkinnyRx as offering quick access to compounded GLP-1s without an appointment but with little support— a fair summary of the tradeoff between speed and clinical depth.

Regulatory flag: On February 20, 2026, the FDA issued Warning Letter #717989 to Lean Rx, Inc., dba SkinnyRx, at its Sacramento, California address. The FDA reviewed the skinnyrx.com website in December 2025 and determined that it made false or misleading claims about compounded semaglutide and tirzepatide products under sections 502(a) and 502(bb) of the FDCA, resulting in misbranded products being introduced into interstate commerce in violation of federal law. The warning letter cited the labeling representations as false or misleading, not manufacturing quality violations — a distinction worth noting, but still a material compliance event from the FDA.